Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis.
Gobejishvili L, Rodriguez WE, Bauer P, Wang Y, Soni C, Lydic T, Barve S, McClain C, Maldonado C.
Gobejishvili L, et al. Among authors: mcclain c.
Drug Des Devel Ther. 2022 May 3;16:1301-1309. doi: 10.2147/DDDT.S355796. eCollection 2022.
Drug Des Devel Ther. 2022.
PMID: 35535222
Free PMC article.